Medicine

Integrating liver endpoints in medical trials of cardiovascular and also kidney disease

.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view calls for addition of people along with MASLD as well as dimension of liver end results in cardio-- kidney-- metabolic tests, when records suggest mechanistically possible advantages and medical protection-- and also summarizes factors to consider for test layout and regulatory commendation.